PTC THERAPEUTICS, INC. ($PTCT)
Boulding Mark Elliott โ EXEC. VP AND CLO
Shares
590
Price
$69.82
Total Value
$41,193.80
Nearby Earnings
Feb 19, 2026
EPS:Est: -0.21
Revenue:Est: $289.25M
Feb 26, 2026
EPS:Est: -0.21
Transaction Details
| Insider | Boulding Mark Elliott |
|---|---|
| Title | EXEC. VP AND CLO |
| Transaction Date | Feb 19, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 23, 2026 |
| Shares Sold | 590 |
| Price per Share | $69.82 |
| Total Value | $41,193.80 |
| Shares Owned After | 105,212 |
| Derivative | No |
| Accession Number | 0001578852-26-000010 |
| Document | View SEC Filing |